Enanta Pharmaceuticals (ENTA) announced Tuesday it would appeal a recent U.S. federal court ruling that favored Pfizer ...

Pfizer's efficiency at spending on R&D and Capex is set to look much better. Click here to see why PFE stock is a Buy.

On Friday, Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.36 which represents a slight increase of $0.59 or 2.29% from the prior close of $25.77. The stock opened at $ and touched a ...

Despite today’s strength, Pfizer shares are trading deep in a long-term bear market trend. The stock crossed into bearish ...

On Thursday, Pfizer Inc (PFE) stock saw a decline, ending the day at $25.77 which represents a decrease of $-0.12 or -0.46% from the prior close of $25.89. The stock opened at $25.7 and touched a low ...

Pfizer stock has been weighed down lately, amid falling revenues and margins. The demand for the Covid-19 vaccine has taken a hit in recent years and the company has been looking to bridge the revenue ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best dividend leaders to buy. Investors have long been drawn to dividend stocks due to their ...

Pfizer (PFE) has received FDA accelerated approval for its drug Braftovi in combination with other therapies for the ...

Dividend-paying stocks provide investors with consistent income in turbulent markets, especially as payouts grow over time.

Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the ...

Pfizer Inc.'s ( NYSE:PFE) periodic dividend will be increasing on the 7th of March to $0.43, with investors receiving 2.4% ...

Vinnie Politan analyzes the case against Luigi Mangione, discussing his new high-profile attorney, Karen Friedman Agnifilo.